Shanrong Biotechnology (SRBT, $0.47) was a top loser over the last three months, falling -1 to $0.47 per share. A.I.dvisor analyzed 155 stocks in the Financial Conglomerates Industry for the 3-month period ending May 19, 2025, and found that of them (7) exhibited an Uptrend while of them (2) demonstrated a Downtrend.